Dare Bioscience Inc (DARE) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.14x
Dare Bioscience Inc (DARE) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting $206.64K (capex $206.64K ) from operating cash flow of $1.44 Million. Explore Dare Bioscience Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
$206.64K
Capex + Investments
Operating Cash Flow
$1.44 Million
USD
Capital Expenditures
$206.64K
USD
Dare Bioscience Inc Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Dare Bioscience Inc across 1 annual periods. Also explore DARE asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dare Bioscience Inc (2024–2024)
Year-by-year capital reinvestment analysis for Dare Bioscience Inc. For live market cap and broader valuation context, see DARE company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | $1.15 Million | $5.39 Million | $573.05K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow